Christine Ann Miller

Christine Ann Miller is a prominent figure in the pharmaceutical and healthcare industry with extensive experience in leadership roles. She currently serves as the Board Chair of the Antimicrobials Working Group (AWG), where she drives innovation and advancements in the antimicrobial ecosystem to optimize patient access.12

Career Highlights

Current Positions::

• President & CEO of Melinta Therapeutics (2020 - Present)1
• Board Member at Iveric Bio (2022 - Present)1
• Board Member at BioNJ (2023 - Present)1

Previous Experience::

• Global Head of Portfolio - Enterprise at Sandoz (2018 - 2020)1
• Various leadership roles at Sandoz, Allergan, and Watson Pharmaceuticals1
• Started her career as a Chemical Engineer at Merck1

Education

Christine holds multiple degrees:

• BS in Chemical Engineering from Rensselaer Polytechnic Institute1
• Master of Technology Management from Stevens Institute of Technology1
• MBA from Stevens Institute of Technology1

Achievements and Recognition

• Named one of the "Most Powerful Women in Corporate America" by Black Enterprise in March 20191
• Speaker at the Generics CEO Summit, McKinsey & Company in 20191
• Panelist for "The Intrapreneurial Mindset – Lead from Within" at the Healthcare Businesswomen's Association in 20201

Leadership Approach

Christine is known for her transformational leadership style, focusing on:

• Establishing clear vision, mission, and strategy
• Driving robust performance outcomes
• Building high-performing teams2

At Melinta Therapeutics, she has led the company's transformation from a pure-play antibiotics business to a leader in acute care, resulting in significant revenue growth and improved employee engagement.2